COCRYSTAL PHARMA, INC. Accounts Payable
COCRYSTAL PHARMA, INC. (COCP) had Accounts Payable of $1.89 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $1.89M.
- 2026-03-31: Accounts Payable, Current $1.37M.
- 2025-12-31: Accounts Payable, Current $890.00K.
- 2025-09-30: Accounts Payable, Current $745.00K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.89M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.37M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $890.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $745.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $856.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $808.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.54M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $859.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.74M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.23M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.22M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $568.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.04M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.65M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $614.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $897.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $616.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $858.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $578.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $491.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $939.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $748.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $657.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $1.49M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $832.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $922.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.51M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $1.09M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.07M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $441.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $616.00K 10-K · filed 2020-03-27 | |
| 2017-12-31 | $494.00K 10-K · filed 2019-04-01 | |
| 2015-09-30 | $724.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $838.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $737.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $299.00K 10-Q · filed 2015-11-16 | |
| 2014-09-30 | $125.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $180.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $289.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $224.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $209.06K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $1.85M 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $1.47M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $589.47K 10-Q · filed 2013-11-18 | $736.28K 10-K · filed 2013-04-01 |
| 2012-09-30 | $1.02M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.61M 10-Q/A · filed 2012-09-28 | |
| 2012-03-31 | $1.17M 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | $1.62M 10-K · filed 2013-04-01 | |
| 2011-09-30 | $2.73M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $1.44M 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | $963.85K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |